Cigna Group launched Medical with Smart Coverage to integrate medical and supplemental health benefits. The product automatically matches medical claims with eligible supplemental benefits to reduce administrative hurdles. This system simplifies high-deductible plans by providing policyholders easier access to cash support during costly health events.
The company projects fiscal year 2026 earnings per share of at least $30.45. Investors are currently evaluating Cigna’s growth potential in specialty pharmacy services. Analysts maintain a Moderate Buy consensus rating on the stock.
Recent institutional activity includes Nykredit A S acquiring a new stake in the company. Conversely, Munich Reinsurance reduced its position in Cigna.